UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antifungal serum concentration monitoring: an update

Journal of antimicrobial chemotherapy, 2008-01, Vol.61 (1), p.17-25

2008

Volltextzugriff (PDF)

Candida glabrata drug:H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug resistance and polyamine homeostasis

Journal of antimicrobial chemotherapy, 2014-07, Vol.69 (7), p.1767-1776

2014

Volltextzugriff (PDF)

PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis

Journal of antimicrobial chemotherapy, 2016-12, Vol.71 (12), p.3528-3535

2016

Volltextzugriff (PDF)

Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania

Journal of antimicrobial chemotherapy, 2014-11, Vol.69 (11), p.2979-2983

2014

Volltextzugriff (PDF)

Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China

Journal of antimicrobial chemotherapy, 2013-04, Vol.68 (4), p.778-785

2013

Volltextzugriff (PDF)

Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India

Journal of antimicrobial chemotherapy, 2014-02, Vol.69 (2), p.555-557

2014

Volltextzugriff (PDF)

Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles

Journal of antimicrobial chemotherapy, 2015-09, Vol.70 (9), p.2556-2565

2015

Volltextzugriff (PDF)

Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy

Journal of antimicrobial chemotherapy, 2014-11, Vol.69 (11), p.3148-3155

2014

Volltextzugriff (PDF)

High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates

Journal of antimicrobial chemotherapy, 2013-03, Vol.68 (3), p.512-514

2013

Volltextzugriff (PDF)

New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?

Journal of antimicrobial chemotherapy, 2016-08, Vol.71 (8), p.2075-2078

2016

Volltextzugriff (PDF)

Liposomal amphotericin B-the present

Journal of antimicrobial chemotherapy, 2022-11, Vol.77 (Suppl_2), p.ii11-ii20

2022

Volltextzugriff (PDF)

Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (7), p.1994-2004

2016

Volltextzugriff (PDF)

Changing epidemiology of candidaemia in Australia

Journal of antimicrobial chemotherapy, 2017-04, Vol.72 (4), p.1103-1108

2017

Volltextzugriff (PDF)

Emergence of multiple fluconazole-resistant Candida parapsilosis sensu stricto clones with persistence and transmission in China

Journal of antimicrobial chemotherapy, 2024-01, Vol.79 (1), p.128-133

2024

Volltextzugriff (PDF)

Exploring synergy between azole antifungal drugs and statins for Candida auris

Journal of antimicrobial chemotherapy, 2023-12, Vol.78 (12), p.2824-2829

2023

Volltextzugriff (PDF)

Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies

Journal of antimicrobial chemotherapy, 2011-02, Vol.66 (2), p.371-374

2011

Volltextzugriff (PDF)

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus

Journal of antimicrobial chemotherapy, 2017-12, Vol.72 (12), p.3325-3333

2017

Volltextzugriff (PDF)

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1522-1526

2015

Volltextzugriff (PDF)

Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013

Journal of antimicrobial chemotherapy, 2020-04, Vol.75 (4), p.849-858

2020

Volltextzugriff (PDF)

High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis

Journal of antimicrobial chemotherapy, 2012-08, Vol.67 (8), p.1870-1873

2012

Volltextzugriff (PDF)

Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris

Journal of antimicrobial chemotherapy, 2019-07, Vol.74 (7), p.1904-1910

2019

Volltextzugriff (PDF)

Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?

Journal of antimicrobial chemotherapy, 2022-04, Vol.77 (5), p.1296-1300

2022

Volltextzugriff (PDF)

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands

Journal of antimicrobial chemotherapy, 2015-01, Vol.70 (1), p.178-181

2015

Volltextzugriff (PDF)

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

Journal of antimicrobial chemotherapy, 2010-10, Vol.65 (10), p.2116-2118

2010

Volltextzugriff (PDF)

Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing

Journal of antimicrobial chemotherapy, 2014-06, Vol.69 (6), p.1633-1641

2014

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Antimicrobial Chemotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(116)

Sprache

Englisch
(116)

Erscheinungsjahr

n.n

Thema

Infectious Diseases
(112)
Life Sciences & Biomedicine
(112)
Microbiology
(112)
Pharmacology & Pharmacy
(112)
Science & Technology
(112)
Antifungal Agents - Pharmacology
(83)
Humans
(83)
Azoles - Pharmacology
(59)
Microbial Sensitivity Tests
(59)
Biological And Medical Sciences
(58)
Medical Sciences
(57)
Pharmacology. Drug Treatments
(57)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(56)
Drug Resistance, Fungal
(37)
Azoles
(36)
Aspergillus Fumigatus - Drug Effects
(29)
Drug Resistance
(27)
Antifungal Agents - Therapeutic Use
(26)
Candida Albicans - Drug Effects
(26)
Candida Albicans
(25)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Antifungal serum concentration monitoring: an update

Candida glabrata drug:H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug resistance and polyamine homeostasis

PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis

Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania

Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China

Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India

Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles

Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy

High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates

New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?

Liposomal amphotericin B-the present

Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa

Changing epidemiology of candidaemia in Australia

Emergence of multiple fluconazole-resistant Candida parapsilosis sensu stricto clones with persistence and transmission in China

Exploring synergy between azole antifungal drugs and statins for Candida auris

Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013

High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis

Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris

Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing

Aktive Filter

Suchergebnisse filtern